Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with hormone-responsive, stage I and II breast cancer: First efficacy results from ABCSG-12

被引：6

作者：

Gnant, M.

Mlineritsch, B.

Schippinger, W.

Luschin-Ebengreuth, G.

Poestlberger, S.

Menzel, C.

Jakesz, R.

Kubista, E.

Marth, C.

Greil, R.

机构：

[1] Med Univ Vienna, Vienna, Austria

[2] Paracelsus Med Univ Salzburg, Salzburg, Austria

[3] Med Univ Graz, Graz, Austria

[4] Hosp Sisters Mercy, Linz, Austria

来源：

关键词：

D O I：

10.1200/jco.2008.26.15_suppl.lba4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA4

引用

页数：1